The Role of dUTPase and Uracil-DNA Repair in Cancer Chemotherapy
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
361-370
Author(s):
Robert D. Ladner
Preface
Journal:
Current Cancer Drug Targets
Volume:
1
Page:
i-i
Author(s):
Ruiwen Zhang
Antisense Anticancer Oligonucleotide Therapeutics
Journal:
Current Cancer Drug Targets
Volume:
1
Page:
177-196
Author(s):
Hui Wang, Gautam Prasad, John K. Buolamwini and Ruiwen Zhang
Antisense and/or Immunostimulatory Oligonucleotide Therapeutics
Journal:
Current Cancer Drug Targets
Volume:
1
Page:
197-209
Author(s):
Sudhir Agrawal and Ekambar R. Kandimalla
Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases
Journal:
Current Cancer Drug Targets
Volume:
1
Page:
211-230
Author(s):
D. R. Mercatante, P. Sazani and R. Kole
Targeting of Cancer-Related Proteins with PNA Oligomers
Journal:
Current Cancer Drug Targets
Volume:
1
Page:
231-239
Author(s):
Margus Pooga and Ulo Langel
D-RNAi (Messenger RNA-antisense DNA Interference) as a Novel Defense System Against Cancer and Viral Infections.
Journal:
Current Cancer Drug Targets
Volume:
1
Page:
241-247
Author(s):
Shi-Lung Lin and Shao-Yao Ying
Preface
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
ii-ii
Author(s):
Alan P. Kozikowski and Pier G. Baraldi
Protein Kinase C Isozymes, Novel Phorbol Ester Receptors and Cancer Chemotherapy
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1725-1744
Author(s):
Orla P. Barry and Marcelo G. Kazanietz
Intercalators as Anticancer Drugs
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1745-1780
Author(s):
M. F. Brana, M. Cacho, A. Gradillas, B. de Pascual-Teresa and A. Ramos